Gano Kyle bought NBIX
February 12, 2025 · Form 4 insider transaction
Gano Kyle bought 19,628 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,628
Price
$0.00
Total value
N/A
InsiderGano Kyle
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2025
Filing dateFebruary 14, 2025
Shares owned after19,628
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.; The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 12, 2026, February 12, 2027, February 12, 2028, and February 12, 2029.